Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Brancatella

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Molecular and Clinical Oncology|February 23, 2018
A patient with MEN1 and end-stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantationAntonio Matrone, Alessandro Brancatella, Piero Marchetti, et al.
Journal of the Endocrine Society|July 13, 2023
Significance of Thyroglobulin Autoantibodies in Patients With Thyroid Cancer Treated With LenvatinibDaniele Sgrò, Piercarlo Rossi, Paolo Piaggi, et al.
European Journal of Endocrinology|November 4, 2021
Hypercalcemia due to CYP24A1 mutations: a systematic descriptive reviewDaniele Cappellani, Alessandro Brancatella, Riccardo Morganti, et al.
The Journal of Clinical Endocrinology and Metabolism|November 29, 2020
Do the Heterozygous Carriers of a CYP24A1 Mutation Display a Different Biochemical Phenotype Than Wild Types?Alessandro Brancatella, Daniele Cappellani, Martin Kaufmann, et al.
Endocrinology, Diabetes & Metabolism Case Reports|October 15, 2019
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four casesIsabella Lupi, Alessandro Brancatella, Mirco Cosottini, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2022
Long-term Efficacy and Safety of Rifampin in the Treatment of a Patient Carrying a CYP24A1 Loss-of-Function VariantAlessandro Brancatella, Daniele Cappellani, Martin Kaufmann, et al.
Case Reports in Endocrinology|May 16, 2019
Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the <i>CYP24A1</i> Gene: A Case Report and Review of the LiteratureDaniele Cappellani, Alessandro Brancatella, Martin Kaufmann, et al.
The Journal of Clinical Endocrinology and Metabolism|June 2, 2023
Cytological and Ultrasound Features of Thyroid Nodules Correlate With Histotypes and Variants of Thyroid CarcinomaDaniele Sgrò, Alessandro Brancatella, Giuseppe Greco, et al.
Endocrine-Related Cancer|April 12, 2023
Thyroid autoimmunity, thyroglobulin autoantibodies, and thyroid cancer prognosisNicola Viola, Laura Agate, Sonia Caprio, et al.
European Thyroid Journal|May 27, 2022
Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockadeAlessandro Brancatella, Laura Pierotti, Nicola Viola, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecular and Clinical Oncology|February 23, 2018
A patient with MEN1 and end-stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantationAntonio Matrone, Alessandro Brancatella, Piero Marchetti, et al.
Journal of the Endocrine Society|July 13, 2023
Significance of Thyroglobulin Autoantibodies in Patients With Thyroid Cancer Treated With LenvatinibDaniele Sgrò, Piercarlo Rossi, Paolo Piaggi, et al.
European Journal of Endocrinology|November 4, 2021
Hypercalcemia due to CYP24A1 mutations: a systematic descriptive reviewDaniele Cappellani, Alessandro Brancatella, Riccardo Morganti, et al.
The Journal of Clinical Endocrinology and Metabolism|November 29, 2020
Do the Heterozygous Carriers of a CYP24A1 Mutation Display a Different Biochemical Phenotype Than Wild Types?Alessandro Brancatella, Daniele Cappellani, Martin Kaufmann, et al.
Endocrinology, Diabetes & Metabolism Case Reports|October 15, 2019
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four casesIsabella Lupi, Alessandro Brancatella, Mirco Cosottini, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2022
Long-term Efficacy and Safety of Rifampin in the Treatment of a Patient Carrying a CYP24A1 Loss-of-Function VariantAlessandro Brancatella, Daniele Cappellani, Martin Kaufmann, et al.
Case Reports in Endocrinology|May 16, 2019
Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the <i>CYP24A1</i> Gene: A Case Report and Review of the LiteratureDaniele Cappellani, Alessandro Brancatella, Martin Kaufmann, et al.
The Journal of Clinical Endocrinology and Metabolism|June 2, 2023
Cytological and Ultrasound Features of Thyroid Nodules Correlate With Histotypes and Variants of Thyroid CarcinomaDaniele Sgrò, Alessandro Brancatella, Giuseppe Greco, et al.
Endocrine-Related Cancer|April 12, 2023
Thyroid autoimmunity, thyroglobulin autoantibodies, and thyroid cancer prognosisNicola Viola, Laura Agate, Sonia Caprio, et al.
European Thyroid Journal|May 27, 2022
Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockadeAlessandro Brancatella, Laura Pierotti, Nicola Viola, et al.
Pageof 3